Blog (Expert Opinion) – Page 4 – Foundation for an Informed Texas
February 3, 2021

Cannabis and Pain Seminar (2/27/21)

Join Informed Texas for this educational seminar on Cannabis and Pain. There is mounting interest among patients and healthcare professionals about the clinical benefits of medical cannabis for various ailments, most commonly for pain relief. A large body of clinical research and a history of anecdotal evidence support the use of cannabis for pain relief.  With a growing number of states enacting robust medical cannabis programs, the most common use for medical cannabis in the US is for pain control. We will examine cannabis’ efficacy, safety profile and impact on opioid use with Pain Specialist Robert Marks, MD and Chase Bearden, T.CUP patient and Deputy Executive Director of Coalition of Texans with Disabilities. (More to be announced.).  This seminar will air on 2/27/21 at 11am CT […]
January 25, 2021

Access to Professional Cannabis Education

Foundation for an Informed Texas is a public non-profit which focuses on cannabis education. During the pandemic, we have focused on creating pertinent and timely virtual educational catalog for Texas. Here is an overview of the content you will enjoy: Ask the Doctors: Join two preeminent doctors in cannabis research, Ethan Russo, MD, and Sue Sisley, MD, for a discussion about medical cannabis, their research findings, and upcoming research projects. Best Practices for Hemp in Texas: As Texas progresses through our inaugural hemp season, education on the burgeoning market is imperative. Our presenters cover: The State of Hemp in Texas  Sustainable Cultivation and Cultivar Selection  Harvesting   Testing and Development  Application and Reporting  Current Research for  Texas ​A&M Agrilife Extension  Fluence Texas Veteran Cannabis Conference: Learn from Texas Agriculture Commissioner […]
January 18, 2021

USDA Poised to Release Final Rule for the U.S. Domestic Hemp Production Program

On January 19, 2021, the USDA will issue the first federal final agency regulation governing hemp production. A sneak peek of the Agricultural Marketing Service (AMS) rule is available here. The final rule will become effective on March 22, 2021. Notable ProvisionsDEA Registration for Testing Laboratories Required for All Labs Testing Hemp (Even Unofficial Samples Throughout the Growing Season) This requirement remains in the final rule Given the limited number of DEA-registered labs currently, enforcement of this requirement will continue to be delayed until December 31, 2022 AMS acknowledged it received comments in opposition to this requirement, but it retains the requirement that any lab testing hemp for regulatory compliance purposes must be registered with the DEA to conduct chemical analysis of controlled substances per 21 CFR […]
December 21, 2020

2020: A Year in Review with Informed Texas

2020 has been full of challenges and opportunities. The pandemic has changed how many of us do business, or in our case, impart education. Informed Texas is proud of the flexible manner in which we have adjusted to this exceptional time in our history. This is due to the unwavering commitment of our board and the dedicated support from our network, sponsors and donors. We are excited to see how our community will continue to grow! Please make a tax-deductible donation today! Download the slideshow.
December 18, 2020

Medical Cannabis White Paper: Policy Recommendations for T.CUP

The Texas Legislature is expected to consider proposals to reform the state’s medical cannabis program during the 2021 legislative session. To help inform this process, Vicente Sederberg LLP has produced a brief white paper, which examines the effectiveness and sustainability of the current Texas Compassionate Use Program (T.CUP) and offers policy recommendations for improving patient access, treatment outcomes, and the economic health of the program. Review the white paper!  The authors also performed a comparative analysis of the T.CUP and healthy medical cannabis programs in other states around the country. In summary, it found that, if Texas enacted the proposed policy recommendations, it would significantly increase patient registration, boost sales, and ensure the viability of the program and its existing business licensee. This larger and more […]